, Tracking Stock Market Picks
Enter Symbol:
galena biopharma (GALE) [hlAlert]

down 12.35 %

galena biopharma (GALE) rated Buy with price target $6 by Aegis Capital

Posted on: Wednesday,  Nov 28, 2012  8:25 AM ET by Aegis Capital

Aegis Capital rated Buy galena biopharma (NASDAQ: GALE) on 11/28/2012, when the stock price was $1.70. Since
then, galena biopharma has lost 12.35% as of 01/21/2016's recent price of $1.49.
If you would have followed this Aegis Capital's recommendation on GALE, you would have lost 12.35% of your investment in 1149 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/28/2012 8:25 AM Buy
1.70 6.00
as of 12/31/2012
1 Week down  -2.54 %
1 Month down  -26.44 %
3 Months down  -10.00 %
1 YTD down  -10.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy